Nikhil Lalwani - 08 Sep 2022 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani
Issuer symbol
ANIP
Transactions as of
08 Sep 2022
Net transactions value
-$137,126
Form type
4
Filing time
12 Sep 2022, 20:15:40 UTC
Previous filing
29 Apr 2022
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability $137,126 -3,646 -1.3% $37.61 281,957 08 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 7,127 shares of restricted stock, the grant of which was previously reported.